Trial Details
UNKNOWNBasic Information
| Clinical ID | c3154 |
|---|---|
| Identifier | NCT02453607 |
| Trial Title | The Impact of 6MP Metabolite Levels on Infliximab Pharmacokinetics and Anti-infliximab Antibodies in Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Inflammatory Bowel Disease|Crohn's Disease |
| Interventions | DRUG: Infliximab|DRUG: thiopurine |
Participant Information
| Sponsor | Ernest Seidman |
|---|---|
| City | Quebec |
| Country/Region | Canada |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | OBSERVATIONAL |
|---|---|
| Phase | NULL |
Time Information
| Start Date | 2014-11-17 |
|---|---|
| Primary Completion Date | 2019-06-30 |
| Completion Date | 2020-06-30 |